NEWS

A COVID-19 Vaccine Snapshot

By Sohini Das
April 28, 2021 10:30 IST

Sputnik V is already approved in India and Sinovac is unlikely to come in as it does not meet the criteria, reports Sohini Das.

IMAGE: A woman receives a dose of Covishield at a vaccination centre in Mumbai, April 26, 2021. Photograph: Niharika Kulkarni/Reuters
 

The Indian government has revised regulations to allow foreign vaccines that have received emergency use authorisation from top regulators into the country.

These are vaccines that have approval from the United States Food and Drug Administration, UK Medicines and Healthcare Products Regulatory Agency, European Medicines Agency, Pharmaceuticals and Medical Devices Agency, Japan, as well as those in the WHO Emergency Use Listing Procedure.

A snapshot of the vaccines that are strong contenders for India.

Of this list, Sputnik V is already approved in India and Sinovac is unlikely to come in as it does not meet the afore-mentioned criteria.

Feature Presentation: Ashish Narsale/Rediff.com

Sohini Das
Source:

Recommended by Rediff.com

NEXT ARTICLE

NewsBusinessMoviesSportsCricketGet AheadDiscussionLabsMyPageVideosCompany Email